OpenAlex
PricingAboutJobs
Log inGet started
Work

Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: Recent advances (2015–2019)

HTML

Year: 2019
Type: review
Source: Bioorganic & Medicinal Chemistry Letters
DOI: 10.1016/j.bmcl.2019.126637
Authors: Concepción Sánchez-Martínez, María José Lallena, Sonia Gutiérrez Sanfeliciano, Alfonso de Dios
Institutions: Eli Lilly (Spain), Eli Lilly (United States)
Language: English

Topic: Advanced Breast Cancer Therapies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: cyclin-dependent kinase inhibitors, CDK4/6 inhibitors, palbociclib, ribociclib, abemaciclib, CDK7 inhibitor, hormone receptor-positive breast cancer, anticancer drug development, cell cycle regulation
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2970349558
FWCI: 3.521
Cites: 137
Cited by: 214
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms